Judith L Thijs (Judith Thijs)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Atopic Dermatitis

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2024)
Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2024)
Roselie E Achten, Judith L Thijs, Marlot van der Wal, Chantal van Luijk, Marlies de Graaf, Daphne S Bakker, Joke de Boer, Femke van Wijk, Marjolein de Bruin-Weller
Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response, and conjunctival goblet cell analysis. Allergy (2023)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)
Roselie E Achten, Daphne S Bakker, Chantal M van Luijk, M Marlot van der Wal, Marlies de Graaf, Femke van Wijk, Nicolaas P A Zuithoff, Lisa P van der Rijst, Celeste M Boesjes, Judith L Thijs, Joke H de Boer, Marjolein de Bruin-Weller
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (6) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Lotte S Spekhorst, Daphne S Bakker, Julia Drylewicz, Theo Rispens, Floris Loeff, Celeste M Boesjes, Judith L Thijs, Geertruida L E Romeijn, Laura Loman, Marie-Louise Schuttelaar, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy 77 (11) (2022)
Daphne S Bakker, José J M Ter Linde, Mojtaba M Amini, Lieneke F M Ariëns, Chantal M van Luijk, Marjolein de Bruin-Weller, Judith L Thijs, Yvonne Vercoulen, Femke van Wijk
Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study. Allergy 76 (12) (2021)
Daphne S Bakker, Lieneke F M Ariëns, Barbara Giovannone, Dirk-Jan Hijnen, Eveline M Delemarre, Edward Knol, Stefan Nierkens, Marjolein de Bruin-Weller, Judith L Thijs, Julia Drylewicz
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Allergy 75 (12) (2020)
Lotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, Marijke Kamsteeg, Albert J Oosting, Ilona de Ridder, Annemiek Sloeserwij, Geertruida L E Romeijn, Marlies de Graaf, Inge Haeck, Judith L Thijs, Marie L A Schuttelaar, Marjolein de Bruin-Weller
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry. Allergy 75 (9) (2020)
Judith L Thijs, Renée Fiechter, Barbara Giovannone, Marjolein de Bruin-Weller, Edward F Knol, Carla A F M Bruijnzeel-Koomen, Julia Drylewicz, Stefan Nierkens, Dirk-Jan Hijnen
Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity. Allergy 74 (11) (2019)
Lieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, Deepak Balak, Margreet L E Romeijn, Tessa Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia Catalina Aurora van Amerongen, Evelien M Delemarre, Edward F Knol, Femke van Wijk, Stefan Nierkens, Judith L Thijs, Marie L A Schuttelaar, Marjolein de Bruin-Weller
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry. Allergy 75 (1) (2019)
Judith L Thijs, Julia Drylewicz, Carla A F M Bruijnzeel-Koomen, Barbara Giovannone, Edward F Knol, Marjolein de Bruin-Weller, Stefan Nierkens, Dirk-Jan Hijnen
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A. Allergy 74 (3) (2018)